TCF7L2 rs358806: Understanding Your Genetic Risk for Diabetes
The rs358806 variant is a common genetic change located within the TCF7L2 gene, which is widely recognized as a significant susceptibility locus for type 2 diabetes. Research indicates that this variant is associated with altered glucose metabolism and may influence how the body secretes insulin.
What each genotype means
Baseline diabetes risk
This genotype represents the most common form of this variant and is not associated with the increased risk of type 2 diabetes observed with the T allele. Individuals with this genotype generally show typical insulin secretion patterns in relation to this specific genetic marker.
This is the most common genotype found across most global populations.
Increased diabetes risk
Carrying one copy of the T allele is associated with a statistically higher risk of developing type 2 diabetes compared to those without it. Research suggests this may be linked to subtle impairments in insulin secretion and glucose metabolism, though lifestyle factors remain significant contributors to overall risk.
This genotype is common, appearing in a significant portion of the population across major ancestral groups.
Elevated diabetes risk
Carrying two copies of the T allele is associated with the highest statistical risk for type 2 diabetes among the three possible genotypes for this variant. This association is linked to reduced insulin secretion and altered glucose processing, though individual risk is heavily influenced by diet, physical activity, and body mass index.
This genotype is found at varying frequencies globally, representing a substantial minority of the population in many regions.
What is the rs358806 Variant?
The rs358806 variant is a single nucleotide polymorphism (SNP) located within the TCF7L2 gene. A SNP represents a variation at a single position in the DNA sequence among individuals. In the case of rs358806, this specific location has been extensively studied in the context of metabolic health. It sits within a region of the genome that has been identified through genome-wide association studies (GWAS) as a hotspot for diabetes-related traits. Because this variant is common, it is found frequently across diverse human populations. Scientists track these variations to understand how subtle differences in our genetic code can contribute to complex health conditions. While the variant itself is just a single letter change in the DNA, its presence is often used as a marker to help researchers identify broader patterns of inherited risk for metabolic disorders.
The Role of the TCF7L2 Gene
The TCF7L2 gene encodes a transcription factor, which is a protein that helps control the activity of other genes. Specifically, this protein is a key component of the Wnt signaling pathway, a complex system that regulates cell development and function. In the context of metabolism, TCF7L2 is highly active in the pancreas, where it plays a crucial role in the function of beta cells. Beta cells are responsible for producing and secreting insulin, the hormone that manages blood sugar levels. When the function of TCF7L2 is altered, it can disrupt the delicate balance of insulin secretion in response to glucose. Research suggests that variations in this gene may lead to impaired insulin release, which is a hallmark of type 2 diabetes. By influencing how beta cells communicate and function, TCF7L2 acts as a central regulator of glucose homeostasis.
Research and Evidence Strength
The association between TCF7L2 variants and type 2 diabetes is considered to have moderate to strong evidence in the scientific literature. Numerous studies, including large-scale meta-analyses and prospective cohort studies, have consistently linked variants in this gene to an increased risk of developing diabetes. The evidence suggests that these variants primarily affect the body's ability to secrete insulin rather than causing insulin resistance directly. While the statistical association is robust across many different ethnic groups, it is important to note that genetics is only one piece of the puzzle. Environmental factors, such as diet, physical activity, and overall lifestyle, play a massive role in the actual development of type 2 diabetes. Therefore, while rs358806 is a well-documented genetic marker, it does not act as a standalone predictor of disease, and its clinical utility is currently focused on research and understanding biological mechanisms.
What You Can and Cannot Do With This Information
Knowing your genotype for rs358806 provides insight into your genetic predisposition, but it is not a medical diagnosis. You cannot use this information to predict with certainty whether you will develop diabetes, nor should it be used to make independent medical decisions. Genetic risk is probabilistic, not deterministic. If you are concerned about your metabolic health, the most effective steps involve consulting with a healthcare professional to discuss standard clinical screenings, such as fasting glucose or HbA1c tests. These clinical markers provide a real-time assessment of your health that is far more actionable than genetic data alone. If you have questions about how your genetic background might influence your health, bring your results to a genetic counselor or your primary care physician. They can help you interpret the information in the context of your personal and family medical history.
How common is this variant?
The rs358806 variant is a common polymorphism found across all major ancestral groups, with the risk-associated alleles appearing at significant frequencies globally.
Frequently asked questions
Does having the risk allele mean I will get diabetes?
No. Genetic variants like rs358806 only indicate a statistical increase in risk. Many people with the risk allele never develop diabetes, and many people without it do.
Can I change my genetic risk for diabetes?
You cannot change your DNA, but you can influence your health outcomes. Lifestyle factors like maintaining a healthy weight, regular exercise, and a balanced diet are proven to significantly lower the risk of type 2 diabetes regardless of your genetics.
Should I get tested for this SNP?
Routine genetic testing for this specific SNP is not currently recommended for clinical diagnosis. If you are concerned about diabetes, speak to your doctor about standard blood sugar screenings.
Is TCF7L2 the only gene linked to diabetes?
No. Type 2 diabetes is a polygenic condition, meaning it is influenced by hundreds of different genetic variants across the entire genome, as well as significant environmental factors.
Sources & further reading
Educational information only, last refreshed 10/13/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs358806?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in TCF7L2
A variant identified in large consortium studies as a contributor to type-2 diabetes susceptibility.
This SNP is associated with an increased risk for type-2 diabetes, contributing to polygenic risk profiles.
Variant in TCF7L2 consistently associated with altered pancreatic beta-cell function and predisposition to type 2 diabetes.
Resides within the TCF7L2 genomic locus, which is strongly linked to altered glucose regulation and type 2 diabetes susceptibility.
This variant is a well-established marker within the TCF7L2 locus, which is recognized as the most potent genetic risk factor for type 2 diabetes across multiple ethnic groups.
This variant is a well-established genetic marker in the TCF7L2 locus associated with impaired insulin secretion and increased risk of type 2 diabetes.